286 related articles for article (PubMed ID: 11290597)
1. Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck).
Newman DK; Hamilton C; Newman PJ
Blood; 2001 Apr; 97(8):2351-7. PubMed ID: 11290597
[TBL] [Abstract][Full Text] [Related]
2. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
Henshall TL; Jones KL; Wilkinson R; Jackson DE
J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
[TBL] [Abstract][Full Text] [Related]
3. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2.
Jackson DE; Kupcho KR; Newman PJ
J Biol Chem; 1997 Oct; 272(40):24868-75. PubMed ID: 9312087
[TBL] [Abstract][Full Text] [Related]
4. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation.
Su MW; Yu CL; Burakoff SJ; Jin YJ
J Immunol; 2001 Mar; 166(6):3975-82. PubMed ID: 11238643
[TBL] [Abstract][Full Text] [Related]
5. SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity.
Cuevas B; Lu Y; Watt S; Kumar R; Zhang J; Siminovitch KA; Mills GB
J Biol Chem; 1999 Sep; 274(39):27583-9. PubMed ID: 10488096
[TBL] [Abstract][Full Text] [Related]
6. Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates.
Hua CT; Gamble JR; Vadas MA; Jackson DE
J Biol Chem; 1998 Oct; 273(43):28332-40. PubMed ID: 9774457
[TBL] [Abstract][Full Text] [Related]
7. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1.
Perez-Villar JJ; Whitney GS; Bowen MA; Hewgill DH; Aruffo AA; Kanner SB
Mol Cell Biol; 1999 Apr; 19(4):2903-12. PubMed ID: 10082557
[TBL] [Abstract][Full Text] [Related]
8. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction.
Newton-Nash DK; Newman PJ
J Immunol; 1999 Jul; 163(2):682-8. PubMed ID: 10395658
[TBL] [Abstract][Full Text] [Related]
9. The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1 (CD31).
Sagawa K; Kimura T; Swieter M; Siraganian RP
J Biol Chem; 1997 Dec; 272(49):31086-91. PubMed ID: 9388260
[TBL] [Abstract][Full Text] [Related]
10. Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31.
Pumphrey NJ; Taylor V; Freeman S; Douglas MR; Bradfield PF; Young SP; Lord JM; Wakelam MJ; Bird IN; Salmon M; Buckley CD
FEBS Lett; 1999 Apr; 450(1-2):77-83. PubMed ID: 10350061
[TBL] [Abstract][Full Text] [Related]
11. Functional requirements for inhibitory signal transmission by the immunomodulatory receptor CD300a.
DeBell KE; Simhadri VR; Mariano JL; Borrego F
BMC Immunol; 2012 Apr; 13():23. PubMed ID: 22537350
[TBL] [Abstract][Full Text] [Related]
12. Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1.
Tourdot BE; Brenner MK; Keough KC; Holyst T; Newman PJ; Newman DK
Biochemistry; 2013 Apr; 52(15):2597-608. PubMed ID: 23418871
[TBL] [Abstract][Full Text] [Related]
13. Platelet endothelial cell adhesion molecule-1 signaling inhibits the activation of human platelets.
Cicmil M; Thomas JM; Leduc M; Bon C; Gibbins JM
Blood; 2002 Jan; 99(1):137-44. PubMed ID: 11756163
[TBL] [Abstract][Full Text] [Related]
14. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
Frearson JA; Alexander DR
J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
[TBL] [Abstract][Full Text] [Related]
15. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
Nakamura K; Brauweiler A; Cambier JC
J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
[TBL] [Abstract][Full Text] [Related]
16. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2.
Gavrieli M; Watanabe N; Loftin SK; Murphy TL; Murphy KM
Biochem Biophys Res Commun; 2003 Dec; 312(4):1236-43. PubMed ID: 14652006
[TBL] [Abstract][Full Text] [Related]
17. Construction and expression of an enzymatically active form of PECAM-1 containing the phosphatase domain of the protein tyrosine phosphatase, SHP-2.
Noda M; Paddock C; Newman PJ
Protein Expr Purif; 2001 Jun; 22(1):113-9. PubMed ID: 11388808
[TBL] [Abstract][Full Text] [Related]
18. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
[TBL] [Abstract][Full Text] [Related]
19. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2.
Barrow AD; Astoul E; Floto A; Brooke G; Relou IA; Jennings NS; Smith KG; Ouwehand W; Farndale RW; Alexander DR; Trowsdale J
J Immunol; 2004 May; 172(10):5838-42. PubMed ID: 15128762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
